Evidence map›Paper›PMID 28349215›Full record

ReviewPediatric nephrology (Berlin, Germany)2018

Adherence in pediatric kidney transplant recipients: solutions for the system.

Elizabeth A Steinberg, Mary Moss, Cindy L Buchanan, Jens Goebel

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04156204 (Kidney Immunosuppression Dosed Daily Only), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04156204 early_phase1terminatednot on this mapstarted 2019, after this paper: background citation

Kidney Immunosuppression Dosed Daily Only (KIDDO) - A Pilot Study

TypeinterventionalSponsorUniversity of Colorado, DenverRan2019 to 2020Enrolled1ConditionsKidney Transplant Rejection, Medication AdherenceArmsMedication Event Monitoring System (MEMS), Once-Daily Tacrolimus extended release
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Post-transplant education for kidney recipients and their caregivers.Pediatric nephrology (Berlin, Germany) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth A SteinbergDepartment of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA. Elizabeth.Steinberg@ucdenver.edu.
Mary MossDepartment of Pharmacy, Children's Hospital Colorado, Aurora, CO, USA.
Cindy L BuchananDepartment of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA.
Jens GoebelDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-adherence remains a significant problem among pediatric (and adult) renal transplant recipients. Non-adherence among solid organ transplant recipients results in US$15-100 million annual costs. Estimates of non-adherence range from 30 to 70% among pediatric patients. Research demonstrates that a 10% decrement in adherence is associated with 8% higher hazard of graft failure and mortality. Focus has begun to shift from patient factors that impact adherence to the contributing healthcare and systems factors. The purpose of this review is to describe problems within the systems implicated in non-adherence and potential solutions that may be related to positive adherence outcomes. Systems issues include insurance and legal regulations, provider and care team barriers to optimal care, and difficulties with transitioning to adult care. Potential solutions include recognition of how systems can work together to improve patient outcomes through improvements in insurance programs, a multi-disciplinary care team approach, evidence-based medical management, pharmacy-based applications and interventions to simplify medication regimens, improved transition protocols, and telehealth/technology-based multi-component interventions. However, there remains a significant lack of reliability in the application of these potential solutions to systems issues that impact patient adherence. Future efforts should accordingly focus on these efforts, likely by leveraging quality improvement and related principles, and on the investigation of the efficacy of these interventions to improve adherence and graft outcomes.

Indexed as

AdolescentChildDelivery of Health CareHumansImmunosuppressive AgentsKidney TransplantationPatient ComplianceRisk FactorsTransplant RecipientsYoung AdultImmunosuppressive AgentsAdherenceHealthcare systemImmunosuppressionKidney transplantPediatricQuality improvement

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.